Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Junctional Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02924909
What this trial is testing

Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer

Who this might be right for
Esophageal CancerInduction Chemotherapy
Instituto Nacional de Cancer, Brazil 50
Not applicableNot Yet RecruitingNCT07260734
What this trial is testing

AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)

Who this might be right for
OESOPHAGO-GASTRIC CARCINOMAOesophageal AdenocarcinomaGastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma+5 more
Imperial College London 6,000
Testing effectiveness (Phase 2)Ended earlyNCT00064259
What this trial is testing

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00084617
What this trial is testing

Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+6 more
National Cancer Institute (NCI) 39
Large-scale testing (Phase 3)Study completedNCT03013010
What this trial is testing

PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy

Who this might be right for
Stomach NeoplasmGastroEsophageal CancerAdenocarcinoma+2 more
Shanghai Cancer Hospital, China 204
Testing effectiveness (Phase 2)Study completedNCT00719550
What this trial is testing

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Who this might be right for
Esophagogastric Junction AdenocarcinomaGastric CancerEsophageal Cancer
Amgen 130
Not applicableLooking for participantsNCT06743490
What this trial is testing

Capturing Key MG-symptoms Using Smartphone Recordings.

Who this might be right for
Myasthenia GravisFatigue
Leiden University Medical Center 225
Testing effectiveness (Phase 2)Looking for participantsNCT07025889
What this trial is testing

IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer

Who this might be right for
Gastric Cancer
Ruijin Hospital 55
Testing effectiveness (Phase 2)Ended earlyNCT05311176
What this trial is testing

IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)

Who this might be right for
Gastric CancerCancer of StomachGastric Adenocarcinoma+3 more
Imugene Limited 7
Early research (Phase 1)Ended earlyNCT00424489
What this trial is testing

Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Northwestern University 9
Large-scale testing (Phase 3)UnknownNCT01523015
What this trial is testing

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal Junction
Medical University of Lublin 100
Not applicableStudy completedNCT03743740
What this trial is testing

The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Hacettepe University 10
Testing effectiveness (Phase 2)UnknownNCT03144843
What this trial is testing

Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.

Who this might be right for
Gastric Cancer
Sun Yat-sen University 110
Early research (Phase 1)UnknownNCT05396326
What this trial is testing

A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Shanghai Zhongshan Hospital 20
Not applicableLooking for participantsNCT04535843
What this trial is testing

Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China

Who this might be right for
Myasthenia Gravis
Huashan Hospital 500
Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Tongji Hospital 36
Testing effectiveness (Phase 2)Study completedNCT00319735
What this trial is testing

Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

Who this might be right for
Esophageal Cancer
Nasser Hanna, M.D. 41
Testing effectiveness (Phase 2)Study completedNCT04923932
What this trial is testing

Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients

Who this might be right for
Gastric CancerEsophagogastric Junction Disorder
Hutchison Medipharma Limited 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT07143604
What this trial is testing

Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
AstraZeneca 33
Large-scale testing (Phase 3)UnknownNCT03914638
What this trial is testing

Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
University of Aarhus 30
Next Page